🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigate the effect of multiple oral doses of BI 207127 + faldaprevir (F...
Status
Terminated
Location
1241.31.2 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT01941615
Treatments Being Tested
The purpose of this study is to evaluate the effect of CC-99677 coadministr...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2020-09-30
Trial ID
NCT04718636
Treatments Being Tested
This cross-sectional comparison and prospective cohort design study will in...
Status
Unknown
Location
Army Health and Performance Laboratory
Start Date
2021-12-01
Trial ID
NCT05587920
The main purpose of this study is to determine the effect of LY3437943 when...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2023-09-12
Trial ID
NCT06039826
Treatments Being Tested
This study is being done to understand if using birth control causes change...
Status
Completed
Location
Center for Family Planning Research
Start Date
2013-08
Trial ID
NCT01873170
The frequency of violence against women, or intimate partner violence (IPV)...
Status
Completed
Location
CHU de Nîmes - Hôpital Universitaire Carémea
Start Date
2023-01-01
Trial ID
NCT05890924
Treatments Being Tested
This study will evaluate the pharmacokinetic properties of rilpivirine and ...
Status
Unknown
Location
Infectious Diseases Institue
Start Date
2018-09-25
Trial ID
NCT03589040
Treatments Being Tested
To evaluate adherence to a single dual-prevention pill (DPP) compared with ...
Status
Not Yet Recruiting
Location
Eswatini Prevention Center CRS
Start Date
2026-05-15
Trial ID
NCT07288190
Treatments Being Tested
A pharmacokinetic drug interaction study of erenumab and an oral contracept...
Status
Completed
Location
Research Site
Start Date
2016-02-12
Trial ID
NCT02792517
Treatments Being Tested
Primary: To assess the effects of repeated dose of Neramexane on the stead...
Status
Completed
Location
AAIharma Deutschland GmbH & Co. KG
Start Date
2009-06
Trial ID
NCT00915174
Treatments Being Tested